Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
PUT
Ubiquiti
UI
$34.7B
| $5.36M | ﹤0.01% |
21,600
-22,600
| -51% | -$6.01M |
|
3577
PUT
Imperial Oil
IMO
$64.5B
| $5.35M | ﹤0.01% |
113,600
+72,500
| +176% | +$3.71M |
|
3578
CALL
Zions Bancorporation
ZION
$10.5B
| $5.35M | ﹤0.01% |
105,100
+36,800
| +54% | +$2.09M |
|
|
KDNY
3579
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.35M | ﹤0.01% |
305,900
+272,500
| +816% | +$4.28M |
|
|
KAIR
3580
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $5.35M | ﹤0.01% |
542,516
-600,101
| -53% | -$5.9M |
|
3581
PUT
Crown Holdings
CCK
$12.9B
| $5.35M | ﹤0.01% |
58,000
+13,500
| +30% | +$1.44M |
|
|
JBGS
3582
JBG SMITH
JBGS
$672M
| $5.34M | ﹤0.01% |
225,791
+109,495
| +94% | +$2.83M |
|
3583
Tilray
TLRY
$643M
| $5.34M | ﹤0.01% |
171,088
+31,915
| +23% | +$1.51M |
|
|
LICY
3584
DELISTED
Li-Cycle Holdings Corp.
LICY
| $5.33M | ﹤0.01% |
96,908
+61,085
| +171% | +$3.57M |
|
3585
PUT
Gen Digital
GEN
$17B
| $5.33M | ﹤0.01% |
242,800
+63,600
| +35% | +$1.56M |
|
3586
CALL
Guidewire Software
GWRE
$14.6B
| $5.33M | ﹤0.01% |
75,100
+21,900
| +41% | +$1.79M |
|
3587
PUT
KraneShares Global Carbon Strategy ETF
KRBN
$132M
| $5.32M | ﹤0.01% |
108,100
-24,600
| -19% | -$1.18M |
|
3588
MGP Ingredients
MGPI
$379M
| $5.32M | ﹤0.01% |
53,163
+18,392
| +53% | +$1.73M |
|
3589
ON Semiconductor
ON
$32.2B
| $5.32M | ﹤0.01% |
105,737
-1,702,093
| -94% | -$94.8M |
|
3590
Ascendis Pharma A/S
ASND
$16.3B
| $5.32M | ﹤0.01% |
+57,188
| New | +$5.39M |
|
|
UCTT
3591
Ultra Clean Holdings
UCTT
$3.85B
| $5.32M | ﹤0.01% |
178,553
+45,917
| +35% | +$1.49M |
|
|
SF
3592
Stifel
SF
$12.9B
| $5.31M | ﹤0.01% |
142,191
-149,235
| -51% | -$6.2M |
|
|
CTLT
3593
DELISTED
CATALENT, INC.
CTLT
| $5.3M | ﹤0.01% |
49,426
+32,183
| +187% | +$3.28M |
|
3594
CALL
Ameriprise Financial
AMP
$50.3B
| $5.3M | ﹤0.01% |
22,300
-16,200
| -42% | -$4.34M |
|
|
HOLX
3595
PUT
DELISTED
Hologic
HOLX
| $5.29M | ﹤0.01% |
76,400
+30,000
| +65% | +$2.23M |
|
3596
PUT
Transocean
RIG
$6.43B
| $5.29M | ﹤0.01% |
1,589,800
-207,400
| -12% | -$840K |
|
3597
PUT
Nutanix
NTNX
$18B
| $5.29M | ﹤0.01% |
361,400
+18,000
| +5% | +$375K |
|
3598
Winnebago Industries
WGO
$892M
| $5.29M | ﹤0.01% |
108,834
-516,226
| -83% | -$26.7M |
|
3599
iShares Gold Trust
IAU
$64.9B
| $5.28M | ﹤0.01% |
153,991
+117,974
| +328% | +$4.2M |
|
|
EVA
3600
CALL
DELISTED
Enviva Inc.
EVA
| $5.28M | ﹤0.01% |
92,300
+35,300
| +62% | +$2.66M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.